Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.

Tobben, Daniel; Carpenter, Sheniece; Kolar, Rachel; Merritt, Tyler; Young, Tramaine; Hauser, Paloma; Collier, Tia

Tobben, Daniel; Carpenter, Sheniece; Kolar, Rachel; Merritt, Tyler; Young, Tramaine; Hauser, Paloma; Collier, Tia.

Afiliação

Tobben D; Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA.
Carpenter S; Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA.
Kolar R; Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA.
Merritt T; Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA.
Young T; Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA.
Hauser P; UNC Gillings School of Global Public Health, Chapel Hill, NC, USA.
Collier T; Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA.

Ann Pharmacother ; : 10600280231205023, 2023 Oct 26.

Article em En | MEDLINE | ID: mdl-37881915

Palavras-chave

ICU; PAMORA; constipation; critically ill; methylnaltrexone; naloxegol; opioid antagonist; opioid-induced constipation; opioids; peripherally acting mu-opioid receptor antagonist

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Pharmacother Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Pharmacother Ano de publicação: 2023 Tipo de documento: Article